Combined medical and surgical treatment of severe vernal keratoconjunctivitis

被引:21
作者
Fujishima, H
Fukagawa, K
Satake, Y
Saito, I
Shimazaki, J
Takano, Y
Tsubota, K
机构
[1] Tokyo Dent Coll, Dept Ophthalmol, Ichikawa, Chiba 2727513, Japan
[2] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan
[3] Univ Tokushima, Sch Dent, Dept Oral Pathol, Tokushima 770, Japan
关键词
corneal complications; cyclosporine A; inflammatory cells; surgical treatment; vernal keratoconjunctivitis;
D O I
10.1016/S0021-5155(00)00210-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: We report the efficacy of an alternative method of treatment for vernal keratoconjunctivitis (VKC) that consists of excision of the palpebral conjunctiva, followed by supratarsal injection of corticosteroid and five times daily topical application of 0.05% cyclosporine A (CsA) and cromolyn sodium. Methods: We evaluated 10 patients with severe treat-resistant VKC with corneal complications. The patients were evaluated for symptoms and for signs, including conjunctival changes, corneal limbal infiltrates, vascularization, reduction of epitheliopathy, meibomitis, visual acuity, intraocular pressure, and pathologic evaluation, before and after treatment. Results: All patients showed marked improvement after 2 weeks of treatment. The symptoms (P < .01), signs (P < .02), and the visual acuity of all patients (P < .01) had significantly improved following treatment. Histological examination showed significant inflammatory cell decreases 4 weeks after surgery (P < .05). Conclusion: Surgery plus topical drug therapy may be useful in treating patients with very severe VKC. (C) 2000 Japanese Ophthalmological Society.
引用
收藏
页码:511 / 515
页数:5
相关论文
共 50 条
  • [21] Vernal keratoconjunctivitis
    Addis, Hampton
    Jeng, Bennie H.
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 119 - 123
  • [22] Management of corneal complications in vernal keratoconjunctivitis: A review
    Feizi, Sepehr
    Javadi, Mohammad Ali
    Alemzadeh-Ansari, Mohammadhasan
    Arabi, Amir
    Shahraki, Toktam
    Kheirkhah, Ahmad
    OCULAR SURFACE, 2021, 19 : 282 - 289
  • [23] Therapeutic options in vernal keratoconjunctivitis
    Messmer, E. M.
    OPHTHALMOLOGE, 2009, 106 (06): : 557 - 561
  • [24] Surgical Resection and Amniotic Membrane Transplantation for Treatment of Refractory Giant Papillae in Vernal Keratoconjunctivitis
    Guo, Ping
    Kheirkhah, Ahmad
    Zhou, Wei-wei
    Qin, Lei
    Shen, Xiao-li
    CORNEA, 2013, 32 (06) : 816 - 820
  • [25] Clnical grading of vernal keratoconjunctivitis
    Bonini, Stefano
    Sacchetti, Marta
    Mantelli, Flavio
    Lambiase, Alessandro
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 7 (05) : 436 - 441
  • [26] Topical cyclosporin a 20% in the treatment of vernal keratoconjunctivitis
    J Mendicute
    C Aranzasti
    F Eder
    J I Ostolaza
    M Salaberria
    Eye, 1997, 11 : 75 - 78
  • [27] Resection and Cryotherapy Combined with Amniotic Membrane Transplantation for the Treatment of Vernal Keratoconjunctivitis with Giant Papillae
    姜冬玲
    张明昌
    胡燕华
    华中科技大学学报(医学英德文版), 2006, (05) : 618 - 620
  • [28] Current and emerging treatment options for vernal keratoconjunctivitis
    Sacchetti, Marta
    Bruscolini, Alice
    Abicca, Irene
    Nebbioso, Marcella
    La Cava, Maurizio
    Bonini, Stefano
    Lambiase, Alessandro
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (04): : 343 - 353
  • [29] Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitis
    Mahdy, Reda A.
    Nada, Waled M.
    Shahien, Ezzat A.
    Boghdadi, Ghada A.
    Marei, Ayman A.
    CUTANEOUS AND OCULAR TOXICOLOGY, 2010, 29 (03) : 198 - 202
  • [30] Topical cyclosporin a 2% in the treatment of vernal keratoconjunctivitis
    Mendicute, J
    Aranzasti, C
    Eder, F
    Ostolaza, JI
    Salaberria, M
    EYE, 1997, 11 (1) : 75 - 78